Erlotinib or Docetaxel for Second-Line Treatment of Non-small Cell Lung Cancer: A Real-World Cost-Effectiveness Analysis
| Autor: | Cromwell, Ian *, van der Hoek, Kimberly *, Melosky, Barbara †, Peacock, Stuart *, ‡ |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology December 2011 6(12):2097-2103 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|